Helmut Salih

Person

Tuebingen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 12,048,744
- Issue date Jul 30, 2024
- Probiocon GmbH
- Helmut Salih
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PSMA binding antibody and uses thereof
- Patent number 11,612,646
- Issue date Mar 28, 2023
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins comprising a binding protein and an interleukin-15...
- Patent number 10,906,952
- Issue date Feb 2, 2021
- Deutsches Krebsforschungszentrum
- Jung Gundram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 10,806,786
- Issue date Oct 20, 2020
- Probiocon GmbH
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of transformed or infected biological cells
- Patent number 7,939,266
- Issue date May 10, 2011
- Eberhard-Karls-Universität Tübingen Universitätsklinikum
- Gernot Stuhler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TARGET-CELL RESTRICTED, COSTIMULATORY, BISPECIFIC AND BIVALENT ANTI...
- Publication number 20230406961
- Publication date Dec 21, 2023
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Helmut SALIH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Binding Antibody and Uses Thereof
- Publication number 20230132249
- Publication date Apr 27, 2023
- Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechtss
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING, AND OTHER MODULATORS OF, THE CD276 ANTIGEN, A...
- Publication number 20230007977
- Publication date Jan 12, 2023
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Gundram Jung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...
- Publication number 20220324931
- Publication date Oct 13, 2022
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Jung GUNDRAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Improved Anti-FLT3 Antigen Binding Proteins
- Publication number 20220056141
- Publication date Feb 24, 2022
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Gundram Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...
- Publication number 20210163564
- Publication date Jun 3, 2021
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Jung GUNDRAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20210128722
- Publication date May 6, 2021
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CANCER COMBINATION TREATMENT
- Publication number 20190218302
- Publication date Jul 18, 2019
- Probiocon GmbH
- Andreas HERRMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Binding Antibody and Uses Therof
- Publication number 20190022205
- Publication date Jan 24, 2019
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ANTIBODY MOLECULE AND ITS USE FOR TARGET CELL RESTRICTE...
- Publication number 20180208657
- Publication date Jul 26, 2018
- JULIUS-MAXIMILIANS-UNIVERSITÄT WURZBURG
- Gundram JUNG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...
- Publication number 20180044391
- Publication date Feb 15, 2018
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Jung GUNDRAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BLOCKING-REAGENTS FOR REDUCING UNSPECIFIC T CELL-ACTIVATION
- Publication number 20170362325
- Publication date Dec 21, 2017
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Gundram JUNG
- G01 - MEASURING TESTING
Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20170319687
- Publication date Nov 9, 2017
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment of transformed or infected biological cells
- Publication number 20080069772
- Publication date Mar 20, 2008
- Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum
- Gernot Stuhler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of transformed or infected biological cells
- Publication number 20060046971
- Publication date Mar 2, 2006
- Gernot Stuhler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Helmut Salih

Person

Patents Grantslast 30 patents

RANKL-specific agent for treating metastatic disease

PSMA binding antibody and uses thereof

Fusion proteins comprising a binding protein and an interleukin-15...

RANKL-specific agent for treating metastatic disease

Treatment of transformed or infected biological cells

Patents Applicationslast 30 patents

TARGET-CELL RESTRICTED, COSTIMULATORY, BISPECIFIC AND BIVALENT ANTI...

PSMA Binding Antibody and Uses Thereof

ANTIBODIES TARGETING, AND OTHER MODULATORS OF, THE CD276 ANTIGEN, A...

FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...

Improved Anti-FLT3 Antigen Binding Proteins

FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

ANTI-CANCER COMBINATION TREATMENT

PSMA Binding Antibody and Uses Therof

RECOMBINANT ANTIBODY MOLECULE AND ITS USE FOR TARGET CELL RESTRICTE...

FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15...

USE OF BLOCKING-REAGENTS FOR REDUCING UNSPECIFIC T CELL-ACTIVATION

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

Treatment of transformed or infected biological cells

Treatment of transformed or infected biological cells